ND
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Donepezil
What it measured
Main measures
to evaluate, by functional RMN, the changes in activation of cortical area involved in execution of cognitive tasks in pre and post treatment phase.
Thinking and memory
Who could take part
Relapsing MS
Inclusion: patients affected by relapsing and remittent SM primarily progressive with a mild cognitive impairment, defined by a score minor than cut off at at least 1 memory test and/or on execution and attention, or to 2 tests related to the same functions; age between 18 and 65; patients able to give their informed consent.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
to evaluate, by functional RMN, the changes in activation of cortical area involved in execution of cognitive tasks in pre and post treatment phase.
Loading reviews and guidelines…
Related trials
- REGAIN
Phase 4 · Stopped early
Stopped early
- OBSERVE
Phase 3 · Completed
Results posted, no main test reported
- A fMRI(Functional Magnetic Resonance Imaging) Research St…
Phase 4 · Completed
No result found
History
Started
Apr 2008
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error